Biofarma Group
Igor Conte has extensive work experience in supply chain management and purchasing. igor most recently served as the Supply Chain Director at Biofarma S.p.a. from July 2019 onwards. Prior to that, they held the position of Purchasing Director at the same company from September 2018 to July 2019. Before joining Biofarma S.p.a., Igor worked at Clivet SpA as the Manager Supply Chain from September 2017 to September 2018, and as the Purchasing Manager from September 2016 to August 2017. igor also worked at Danieli as the Purchasing Director from July 2012 to August 2016, and as the Purchasing Manager from July 2008 to July 2012. Igor's earlier work experience includes roles such as Purchasing Manager at Trevolution Shanghai from September 2005 to July 2008, and Project Manager at IMQ S.p.A. from September 2002 to July 2005. igor started their career as a Buyer at De'Longhi from December 2001 to September 2002.
Igor Conte pursued a Master's degree in Electric Engineering at the Università degli Studi di Trieste from 1995 to 2001. It is not known when Igor began or concluded their education at ITSG A Palladio, and no degree or field of study information is available for this institution.
This person is not in any offices
Biofarma Group
1 followers
Biofarma Group is the global player that develops, produces and packages food supplements, medical devices, probiotic-based drugs and cosmetics, exclusively for third parties. Including 4 production sites in Italy (Friuli Venezia Giulia - HQ, Veneto and Lombardy), 2 production sites in France, 1 in the USA and 1 in China, Biofarma Group offers customized solutions and a comprehensive service, from the development of the idea to the finished product. The Company offers to customers a broad catalogue of products ready for distribution, some of them with clinical studies, and medical devices available in out-licensing including dossiers, some of them patented, with the possibility of being marketed all over the world. Innovation, competence and excellence are the values that, combined with investments in production processes, cutting-edge machinery and human capital, allow the Group to represent, globally, a highly attractive and competitive landmark in the development and manufacture of Health-Care and Beauty Care products.